HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Cholestatic hepatitis — Clinical Guidelines

Overview

Cholestatic hepatitis encompasses a spectrum of liver disorders characterized by impaired bile flow, leading to jaundice, pruritus, and potential progression to liver failure 1 2 3.

Diagnosis

Clinical History and Physical Examination: Essential for initial assessment 1.

Laboratory Tests: Elevated bilirubin, alkaline phosphatase, and transaminases 1.

Imaging Studies: Ultrasound, MRI, or MRCP to evaluate biliary anatomy 1.

Genetic Testing: Advanced diagnostic tool for identifying genetic causes 1 2.

Liver Biopsy: Histological evaluation crucial for confirming diagnosis and guiding management 3.

Bile Acid Analysis: Useful in identifying specific metabolic defects 10.

Management

Supportive Care: Management of symptoms including pruritus 4 7.

Vitamin Supplementation: Address deficiencies in fat-soluble vitamins (A, D, E, K) 5 7.

Cholestyramine: Used for pruritus and to manage steatorrhea 6 7.

Naltrexone: Effective in reducing cholestatic pruritus; dose not specified 4.

Ursodeoxycholic Acid: Considered for specific cholestatic conditions 6.

Immunosuppressive Therapy: Prednisolone or other agents in selected cases 6.

Special Populations

Pediatrics: Early diagnosis crucial, especially for biliary atresia; newborn screening beneficial 1.

Comorbidities: Consider impact on liver function and nutritional status in managing deficiencies 5 6.

Key Recommendations

Implement newborn screening for early identification of cholestatic conditions (Evidence: Strong 1).

Utilize genetic testing to diagnose genetic cholestatic liver diseases effectively (Evidence: Moderate 2).

Regularly monitor and supplement fat-soluble vitamins in patients with chronic cholestasis to prevent deficiencies (Evidence: Moderate 5 7).

Consider naltrexone for symptomatic relief of cholestatic pruritus, weighing potential side effects (Evidence: Weak 4).

Refer patients to tertiary centers for comprehensive management, especially in complex or genetic cases (Evidence: Expert opinion 2).

References

1 Chen HL, Taylor SA, Lee WS, Ciocca M, El-Guindi MA, Yachha SK et al.. Diagnostic approaches for infants with cholestatic liver diseases: Position paper and perspectives of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of pediatric gastroenterology and nutrition 2025. link 2 . EASL Clinical Practice Guidelines on genetic cholestatic liver diseases. Journal of hepatology 2024. link 3 Cho SJ, Perito ER, Shafizadeh N, Kim GE. Dialogs in the assessment of neonatal cholestatic liver disease. Human pathology 2021. link 4 Murray-Brown FL. Naltrexone for cholestatic itch: a systematic review. BMJ supportive & palliative care 2021. link 5 Kowdley KV. Lipids and lipid-activated vitamins in chronic cholestatic diseases. Clinics in liver disease 1998. link70013-1) 6 Koçak N, Gürakan F, Yüce A, Cağlar M, Kale G, Göğüş S. Nonsyndromic paucity of interlobular bile ducts: clinical and laboratory findings of 10 cases. Journal of pediatric gastroenterology and nutrition 1997. link 7 Sokol RJ. Fat-soluble vitamins and their importance in patients with cholestatic liver diseases. Gastroenterology clinics of North America 1994. link 8 Nakayama H, Mihara M, Shimao S. Perineural xanthoma. The British journal of dermatology 1986. link 9 Waxman DJ. Rat hepatic cholesterol 7 alpha-hydroxylase: biochemical properties and comparison to constitutive and xenobiotic-inducible cytochrome P-450 enzymes. Archives of biochemistry and biophysics 1986. link90592-8) 10 Freese DK, Hanson RF. Neonatal cholestatic syndromes associated with alterations in bile acid synthesis. Journal of pediatric gastroenterology and nutrition 1983. link

Cholestatic hepatitis